194 related articles for article (PubMed ID: 28885052)
1. Migraine and vascular disease biomarkers: A population-based case-control study.
Tietjen GE; Khubchandani J; Herial N; Palm-Meinders IH; Koppen H; Terwindt GM; van Buchem MA; Launer LJ; Ferrari MD; Kruit MC
Cephalalgia; 2018 Mar; 38(3):511-518. PubMed ID: 28885052
[TBL] [Abstract][Full Text] [Related]
2. Migraine and biomarkers of endothelial activation in young women.
Tietjen GE; Herial NA; White L; Utley C; Kosmyna JM; Khuder SA
Stroke; 2009 Sep; 40(9):2977-82. PubMed ID: 19608996
[TBL] [Abstract][Full Text] [Related]
3. Serum levels of pentraxin-3 and other inflammatory biomarkers in migraine: Association with migraine characteristics.
Ceylan M; Bayraktutan OF; Becel S; Atis Ö; Yalcin A; Kotan D
Cephalalgia; 2016 May; 36(6):518-25. PubMed ID: 26243757
[TBL] [Abstract][Full Text] [Related]
4. Hypercoagulability and Migraine.
Tietjen GE; Collins SA
Headache; 2018 Jan; 58(1):173-183. PubMed ID: 28181217
[TBL] [Abstract][Full Text] [Related]
5. C-reactive protein in migraine sufferers similar to that of non-migraineurs: the Reykjavik Study.
Gudmundsson LS; Aspelund T; Scher AI; Thorgeirsson G; Johannsson M; Launer LJ; Gudnason V
Cephalalgia; 2009 Dec; 29(12):1301-10. PubMed ID: 19438929
[TBL] [Abstract][Full Text] [Related]
6. The impact of C-reactive protein levels on headache frequency in the HUNT study 2006-2008.
Hagen K; Stovner LJ; Nilsen KB; Kristoffersen ES; Winsvold BS
BMC Neurol; 2019 Sep; 19(1):229. PubMed ID: 31558164
[TBL] [Abstract][Full Text] [Related]
7. Diurnal, seasonal, and blood-processing patterns in levels of circulating fibrinogen, fibrin D-dimer, C-reactive protein, tissue plasminogen activator, and von Willebrand factor in a 45-year-old population.
Rudnicka AR; Rumley A; Lowe GD; Strachan DP
Circulation; 2007 Feb; 115(8):996-1003. PubMed ID: 17296859
[TBL] [Abstract][Full Text] [Related]
8. Association Between Hemostatic Profile and Migraine: A Mendelian Randomization Analysis.
Guo Y; Rist PM; Sabater-Lleal M; de Vries P; Smith N; Ridker PM; Kurth T; Chasman DI
Neurology; 2021 May; 96(20):e2481-e2487. PubMed ID: 33795393
[TBL] [Abstract][Full Text] [Related]
9. The relationship between levels of plasma-soluble urokinase plasminogen activator receptor (suPAR) and presence of migraine attack and aura.
Yılmaz N; Yılmaz M; Sirin B; Yılmaztekin S; Kutlu G
J Recept Signal Transduct Res; 2017 Oct; 37(5):447-452. PubMed ID: 28553881
[TBL] [Abstract][Full Text] [Related]
10. Does insomnia modify the association between C-reactive protein and migraine? The Tromsø Study 2015-2016.
Hagen K; Hopstock LA; Elise Eggen A; Mathiesen EB; Nilsen KB
Cephalalgia; 2019 Jul; 39(8):1022-1029. PubMed ID: 30862180
[TBL] [Abstract][Full Text] [Related]
11. C-reactive protein may be increased in migraine patients who present with complex clinical features.
Welch KM; Brandes AW; Salerno L; Brandes JL
Headache; 2006 Feb; 46(2):197-9. PubMed ID: 16492227
[TBL] [Abstract][Full Text] [Related]
12. High sensitivity C-reactive protein and cerebral white matter hyperintensities on magnetic resonance imaging in migraine patients.
Avci AY; Lakadamyali H; Arikan S; Benli US; Kilinc M
J Headache Pain; 2015; 16():9. PubMed ID: 25595197
[TBL] [Abstract][Full Text] [Related]
13. Evidence that blood-CSF barrier transport, but not inflammatory biomarkers, change in migraine, while CSF sVCAM1 associates with migraine frequency and CSF fibrinogen.
Cowan RP; Gross NB; Sweeney MD; Sagare AP; Montagne A; Arakaki X; Fonteh AN; Zlokovic BV; Pogoda JM; Harrington MG
Headache; 2021 Mar; 61(3):536-545. PubMed ID: 33724462
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of serum transforming growth factor β1 and C-reactive protein levels in migraine patients.
Güzel I; Taşdemir N; Celik Y
Neurol Neurochir Pol; 2013; 47(4):357-62. PubMed ID: 23986426
[TBL] [Abstract][Full Text] [Related]
15. Adverse childhood experiences are associated with migraine and vascular biomarkers.
Tietjen GE; Khubchandani J; Herial NA; Shah K
Headache; 2012 Jun; 52(6):920-9. PubMed ID: 22533684
[TBL] [Abstract][Full Text] [Related]
16. Role of hemostatic risk factors for restenosis in peripheral arterial occlusive disease after transluminal angioplasty.
Tschopl M; Tsakiris DA; Marbet GA; Labs KH; Jäger K
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3208-14. PubMed ID: 9409313
[TBL] [Abstract][Full Text] [Related]
17. Correlation of Inflammation and Lipoprotein (a) with Hypercoagulability in Hemodialysis Patients.
Topçiu-Shufta V; Haxhibeqiri V; Begolli L; Baruti-Gafurri Z; Veseli S; Haxhibeqiri S; Miftari R; Kurti L; Avdiu D
Med Arch; 2015 Aug; 69(4):232-5. PubMed ID: 26543308
[TBL] [Abstract][Full Text] [Related]
18. Elevated plasma fibrin D-dimer as a risk factor for vascular dementia: the Three-City cohort study.
Carcaillon L; Gaussem P; Ducimetière P; Giroud M; Ritchie K; Dartigues JF; Scarabin PY
J Thromb Haemost; 2009 Dec; 7(12):1972-8. PubMed ID: 19735443
[TBL] [Abstract][Full Text] [Related]
19. Evidence for activation of the coagulation system in migraine with aura.
Hering-Hanit R; Friedman Z; Schlesinger I; Ellis M
Cephalalgia; 2001 Mar; 21(2):137-9. PubMed ID: 11422096
[TBL] [Abstract][Full Text] [Related]
20. Markers of endothelial function in migraine patients: Results from a bi-center prospective study.
Fischer M; Gaul C; Shanib H; Holle D; Loacker L; Griesmacher A; Lackner P; Broessner G
Cephalalgia; 2015 Sep; 35(10):877-85. PubMed ID: 25533714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
